Cargando…
Thrombozytenaggregationshemmer (Update 2023)
Acute thrombotic complications as a key feature of accelerated atherothrombotic disease typically precipitate cardiovascular events and therefore strongly contribute to cardiovascular morbidity and mortality in patients with diabetes. Inhibition of platelet aggregation can reduce the risk for acute...
Autores principales: | Wascher, Thomas C., Stulnig, Thomas M., Saely, Christoph H., Stechemesser, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133352/ https://www.ncbi.nlm.nih.gov/pubmed/37101038 http://dx.doi.org/10.1007/s00508-023-02168-6 |
Ejemplares similares
-
Blutzuckerselbstkontrolle Update 2023
por: Wascher, Thomas C., et al.
Publicado: (2023) -
Lipide: Diagnostik und Therapie bei Diabetes mellitus (Update 2023)
por: Wascher, Thomas C., et al.
Publicado: (2023) -
Diabetes mellitus, koronare Herzkrankheit und Herzinsuffizienz (Update 2023)
por: Clodi, Martin, et al.
Publicado: (2023) -
Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2023)
por: Clodi, Martin, et al.
Publicado: (2023) -
Diabetesmanagement im Krankenhaus (Update 2023)
por: Mader, Julia K., et al.
Publicado: (2023)